Cargando…
miR-186 promotes tumor growth in cutaneous squamous cell carcinoma by inhibiting apoptotic protease activating factor-1
Cutaneous squamous cell carcinoma (cSCC) accounts for 20% of non-melanoma skin cancer worldwide. MicroRNAs (miRNAs or miRs) are a subtype of non-coding RNA associated with the progression of various types of human cancer. MiR-186 has been demonstrated to act as an oncogene in human tumors. However,...
Autores principales: | Tian, Jing, Shen, Rui, Yan, Yuzhang, Deng, Liehua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176155/ https://www.ncbi.nlm.nih.gov/pubmed/30344679 http://dx.doi.org/10.3892/etm.2018.6679 |
Ejemplares similares
-
miR186 suppresses prostate cancer progression by targeting Twist1
por: Zhao, Xian, et al.
Publicado: (2016) -
miR-186-ANXA9 signaling inhibits tumorigenesis in breast cancer
por: Wang, Zhongrui, et al.
Publicado: (2023) -
Hsa_circ_0005085 may suppress cutaneous squamous cell carcinoma growth and metastasis through targeting the miR‐186‐5p/LAMC1 axis
por: Wang, Lipeng, et al.
Publicado: (2023) -
MiR-186 suppresses the growth and metastasis of bladder cancer by targeting NSBP1
por: Yao, Kun, et al.
Publicado: (2015) -
MiR-223 and MiR-186 Are Associated with Long-Term Mortality after Myocardial Infarction
por: Elbaz, Meyer, et al.
Publicado: (2022)